<DOC>
	<DOCNO>NCT01728532</DOCNO>
	<brief_summary>TRIAL TITLE : Open , randomized multicentric trial evaluate efficacy clinical tolerance PA0903 root canal sealer SPONSOR : SEPTODONT , 58 rue du Pont de Créteil , 94107 Saint Maur des Fossés cedex Tel : + 33 1-49-76-74-26 , Fax . : + 33 1- 49-76-71-91 Reference protocol : 11/001 PRODUCT NAME : PA0903 MEDICAL DEVICE : Class III : Root canal sealer Dose : applicable Application : one single time DEVELOPMENTAL PHASE : applicable ( medical device class III )</brief_summary>
	<brief_title>Open , Multicentric Trial Evaluating Efficacy Clinical Tolerance PA0903 Root Canal Sealer</brief_title>
	<detailed_description>METHODOLOGY : This study perform adult require non-surgical root canal obturation . The studied indication root canal sealing . This multi-centre open-label study comprise two group correspond tested root canal sealer ( reference product investigational product ) . Randomization require . Investigational product dental cement base biosilicate technology ( PA0903 ) apply lateral compaction single cone technique . On contrary , reference product zinc oxide-eugenol used dental practice ( Pulp Canal Sealer ) apply single wave technique . Study start : 01/12/11 Inclusion period : 24 month Study duration : 2 year end inclusion period OBJECTIVES : The trial objective illustrate clinical radiographic outcome PA0903 describe indication . Primary objective : The primary objective evaluate : clinical radiographic outcome root canal treatment two year use PA0903 endodontic sealer gutta-percha . The success rate define pain ( score 0 VAS scale ) absence decrease size LEO ( fulfilment Strindberg 's criterion ) . If pre-existing lesion , size decrease associate normal contour , width structure periodontal margines consider success . All case lesion increase stabilize 2 year judge unsuccessful . Moreover , case Strindberg 's criterion suitable fulfil judged unsuccessful . A follow-up two year describe predictive time success . Secondary objective : The secondary objective evaluate follow criterion indicative way , compare patient receive PA0903 receive reference product : - The success rate time point also components composite variable ( i.e . pain Healing process total class ( vital teeth necrotic teeth ) endodontic status teeth ) . In case pre-existing LEO associate necrotic teeth , size LEO suitable Strindgberg 's criterion use judge outcome root canal therapy describe : At visit 2 ( 6 month ) treatment consider successful LEO stable decrease comparison V0 associate Strindberg 's criterion suitable . At V3 ( 1 year ) , treatment consider successful LEO decrease comparison V2 associate Strindberg 's criterion suitable . - Healing process associate PA0903 application endodontic status - handling , consistency physical characteristic PA0903 - longevity safety product associate PA0903 two year . TRIAL POPULATION AND NUMBER OF PATIENTS : 60 patient include study , 20 center ratio 2 ( PA0903 ) : 1 ( reference ) . Adults include without gender distinction . Coordinating center Endodotontic service Pitié Salpétrière Pitié Salpétrière Hospital 75634 Paris Cedex 13 France DURATION OF TREATMENT : The product apply D0 ( inclusion ) study . The follow-up period include 2 year 4 visit : Visit 1 ( Week 2 ) , Visit 2 ( Month 6 ) , Visit 3 ( Year 1 ) Visit 4 ( Year 2 ) .</detailed_description>
	<criteria>Inclusion Criteria Male female &gt; 18 year old provide sign , informed consent . affiliate social security . In addition , subject must fulfill follow criterion root canal sealer treatment : Permanent mature single root teeth : maxillary incisor , mandibular incisor one canal , upper low canine , upper low premolar one canal Permanent mature mandibular molar Pulp status Vital pulp need pulpectomy without clinical and/or radiological finding apical periodontitis . Irreversible pulpitis without pain Non infect tooth positively respond pulp vitality test Or necrotic pulp without radiographic sign apical pathosis Periodontal status No active periodontal disease Exclusion criterion : History malignancy last 5 year . Systemic disease stabilize within 1 month Inclusion Visit ( e.g. , diabetes , thyroid malfunction , uncontrolled autoimmune disease ) judge investigator incompatible study ( e.g . current systemic infection ) condition incompatible frequent assessment need study . Risk A cardiopathy Known hypersensitivity one component study procedural medication . Presence history severe systemic allergy . Presence history drug addiction alcohol abuse . Patient participate clinical trial new active substance month study entry . Participation another clinical study time present study . Known pregnancy lactation study entry . Patients legal protection Specific criterion relative root canal sealing : Extreme curvature canal Dilacerations Root dilacerations sharp apical curvature mandibular molar Superimposition mesial canal mandibular molar Large periapical radiolucencies Periodontal disease Not primary endodontic treatment Perforated root canal Supracrestal iatrogenic perforation Inadequate insufficient periodontal support Combined endoperiodontal lesion Loss tooth structure ( Coronal decay and/or concomitant root decay ) compromise tooth 's maintenance dental arch )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>